from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0527/ccdA

LFCtreatmentdescriptionclass of inhibitor

-0.901

Amikacinug/mL Amikacintranslation

-2.306

Cap5-10ug/mL Capreomycintranslation

-1.996

Rox10-50 ug/mL Roxithromycintranslation

-0.321

SM2-5 ug/mL Streptomycintranslation

-1.400

Tet5-10 ug/mL Tetracyclinetranslation

0.781

Rif0.2-5ug/mL Rifampicintranscription

-0.238

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.274

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.952

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.945

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.441

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.295

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.099

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.718

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.242

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.615

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.968

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.673

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.313

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.822

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.299

KCN5-20 ug/mL Potassium cyaniderespiration

-0.213

NaN30.2-2 mM Sodium aziderespiration

-0.811

Nigericin50 uM Nigericinrespiration

0.119

TRC10-150 ug/mL Triclosanrespiration

-1.712

TRZ10-25 ug/mL Thioridazinerespiration

-2.113

Valinomycin0.5-10 uM Valinomycinrespiration

-1.153

ZnSO42 mM ZnSO4respiration

-0.578

menadione6-10 ug/mL Menadionerespiration

-0.566

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.202

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.156

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.125

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.827

NRP_1Non-replicating persistence stage 1dosRassociated

0.018

Amp0.2mg/mL AmpicillincellWall

0.243

Cephalexin20-100 ug/mL CephalexincellWall

-0.038

Cerulenin0.32-5 ug/mL CerulenincellWall

0.723

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.368

EMB10-20 ug/mL EthambutolcellWall

-0.223

Eta12-40 ug/mL EthionamidecellWall

0.057

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.141

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.619

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.227

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.769

BZA0.12 mg/mL BenzamidearomaticAmides

0.973

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.851

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.286

H2O24 mM hydrogen peroxideDNAdamaging

-0.459

Levo10 ug/mL LevofloxacinDNAdamaging

0.901

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.364

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.042

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.473

UVUV-irradiationDNAdamaging

-1.405

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.027

Antimycin12.5-50 ug/mL Antimycin A?

-0.409

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.360

PA_110-50 ug/mL Antitubercular compound PA-1?

0.293

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.701

PA8240.2-2 ug/mL PA-824?

1.025

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.781

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.690

Verapamil50 uM Verapamil?

-0.295

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.297

methoxatin10-20 ug/mL Methoxatin?